Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-02-22 @ 9:39 AM
Study NCT ID:
NCT00864435
Status:
COMPLETED
Last Update Posted:
2010-08-16
First Post:
2009-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Fasting Conditions
Sponsor:
Actavis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
3159
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Meena Venugopal, Director, Clinical R&D
Old Organization:
Actavis Inc